Stock Price
0.62
Daily Change
0.08 14.95%
Monthly
32.26%
Yearly
521.21%
Q2 Forecast
0.50

Starpharma Holdings reported AUD15.41M in Cash and Equivalent for its fiscal semester ending in June of 2025.





Cash And Equivalent Change Date
Medical Developments International AUD 17.84M 219K Jun/2025
Mesoblast USD 129.57M 31.58M Dec/2025
Neuren Pharmaceuticals AUD 5.91M 2.76M Jun/2025